Health experts have issued a direct call for eligible students and young people to book their MenB vaccinations before the new academic year begins. The initiative, announced on 12 June 2026, represents a focused public health response grounded in evidence of elevated risk rather than broad mandates.
The one-off national programme covers those born between 1 September 2007 and 31 August 2008, currently in Year 13 or equivalent, together with under-25s starting university or residential further education for the first time this autumn. Two doses of the vaccine, administered at least four weeks apart, are required for maximum protection against most strains of meningococcal B disease.
In England the vaccine is available through GPs and participating pharmacies. Comparable arrangements operate across the other UK nations. First doses became available from 20 July 2026, with the programme continuing through the end of the year for initial appointments.
The decision follows recent MenB outbreaks and clusters. University students face approximately seven times the risk of meningococcal disease compared with non-students of the same age. Meningococcal B disease remains rare yet carries a fatality rate of up to 10 per cent and can result in lifelong injury.
While MenB outbreaks are uncommon, when they occur, they can be devastating as recent outbreaks have sadly shown. The risk is higher among young people starting university where close and prolonged contact with lots of new people increases the chances of being exposed to the meningococcal bacteria. Two doses of the MenB vaccine is essential and will give good protection against most strains and help to give young people and their families some reassurance.
Dr Shamez Ladhani of UKHSA delivered that assessment in the official announcement. His remarks underline the programme's intent to shield a clearly defined high-risk group through established medical intervention. Protection from two doses is expected to last at least five years, offering reassurance to students and their families during a period of significant social mixing in close quarters.
Dr Thomas Waite, deputy chief medical officer, reinforced the urgency.
